Physician profile
Michael A Rogoff
NPI 1104803436
$26,286.04
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,283 · 2020: $30.41 · 2021: $357 · 2022: $5,072 · 2023: $10K · 2024: $8,376.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $18K · Food and Beverage: $210.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $18,333.33 |
| Food and Beverage | $209.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $23,659.27 | 2021-2024 | Auryon Laser System 100-120 Vac, Solero |
| Cardiovascular Systems INC. | $2,322.70 | 2019-2023 | Diamondback Peripheral |
| Janssen Pharmaceuticals, INC | $76.81 | 2021-2022 | |
| Endologix LLC | $53.43 | 2023-2024 | |
| Boston Scientific Corporation | $51.30 | 2021-2024 | Varithena Administration Pack |
| Cordis US Corp. | $37.39 | 2023 | Mynx Control, Saber |
| Biocompatibles, INC. | $23.63 | 2019 | |
| Abbott Laboratories | $22.08 | 2023 | Diamondback Peripheral |
| Cook Medical LLC | $20.17 | 2020 | |
| Smith+Nephew, INC. | $19.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Rogoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.